Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Office-based medical practice can promote vaccination in adults

Promoting immunizations as a part of routine office-based medical practice is needed to improve adult vaccination rates, a highly effective way to curb the spread of diseases across communities, prevent needless illness and deaths, and lower health care costs, according to a new RAND Corporation study.

12 Jan 2012

Obesity linked to higher rates of prostrate cancer screening across race/ethnicity and gender

Researchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women.

10 Jan 2012

QIAGEN's therascreen EGFR Mutation Detection Kit receives Japanese regulatory approval

QIAGEN today announced the regulatory approval of its therascreen EGFR Mutation Detection Kit RGQ in Japan. EGFR, the epidermal growth factor receptor, has been shown to play an important role in certain cancers and is the target of many new anticancer drugs.

From QIAGEN Manchester Limited 10 Jan 2012

MPIIB, QIAGEN partner to develop latent TB diagnostic test

QIAGEN N.V. and the Max Planck Institute for Infection Biology (MPIIB), Department of Immunology have announced a new collaboration to develop a molecular diagnostic test to assess the risk of an individual with latent tuberculosis (TB) developing active TB disease during their lifetime.

From QIAGEN Manchester Limited 9 Jan 2012

Vinegar may easily detect cervical cancer

Vinegar may be more useful than realised. Its could offer the ability to find precancerous lesions in the cervix and potentially save thousands of women’s lives say researchers.

8 Jan 2012

Smokeless tobacco products in India associated with increased risk of oral cancer

The 2nd International Conference on the Frontiers in Prevention, Diagnosis & Therapy of Cancer was held on 7th Jan. 2012 at Allahabad, India and looked at the relationship of oral cancer with tobacco habits. Various innovations in oral cancer diagnosis, therapy and tobacco usage were discussed by experts from around the world.

7 Jan 2012

QIAGEN introduces QIAensemble Decapper to facilitate handling of liquid samples

QIAGEN N.V. announced today the launch of the QIAensemble Decapper automation system that will facilitate the handling of liquid-based cytology and various other types of liquid samples that are processed by clinical laboratories around the world.

From QIAGEN Manchester Limited 6 Jan 2012

Experts share 10 symptoms of cervical and other gynecologic cancers

Pelvic pain and abnormal bleeding aren't the only signs of gynecologic cancer. As part of Cervical Health Awareness Month in January, experts at The University of Texas MD Anderson Cancer Center share other symptoms that often are overlooked.

6 Jan 2012

Additional financing to fund Advaxis' cervical cancer trials

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has entered into a definitive Convertible Notes Purchase Agreement (Agreement) with certain accredited investors, for the purchase of the aggregate principal value of approximately $1.2 million of Convertible Promissory Notes (Notes) for an aggregate purchase price of approximately $1.0 million.

31 Dec 2011

Jenna Bush Hager reports on family trip to Africa to visit health programs on NBC's Today Show

In this video clip from NBC's Today show, contributing correspondent Jenna Bush Hager reports on a recent family trip to Africa to visit PEPFAR-funded programs and to announce a new initiative by the George W. Bush Institute to fight cervical cancer.

23 Dec 2011

HPV vaccine support by GAVI example of 'equity in health'

Noting that human papillomavirus (HPV) causes 70 percent of cervical cancer cases worldwide, Mary Robinson, former president of Ireland and former GAVI Alliance Board chair, writes in this BMJ Group Blogs post that the GAVI Alliance's decision to support the introduction of HPV vaccine among women in developing countries "is an important example of how we must continue to strive for equity in health. And it will help ensure that the world's less-privileged women remain the strength behind their children, their families, and their communities."

22 Dec 2011

Gardasil – cervical cancer vaccine offered to all boys as well

Soon all adolescent boys may be vaccinated against the sexually transmitted disease that causes some forms of cancer under an extension of a scheme now available to girls, the Australian government's expert panel has recommended. The committee adds that the shots would also widen immunity to the virus, which would further reduce the risk to women and stem the spread of genital warts in both sexes.

19 Dec 2011

HPV test outshines Pap smears for detection of early cervical cancers

A new trial involving nearly 40,000 women in the Netherlands showed that testing for the human papillomavirus, or HPV allowed doctors to detect abnormal cervical cells earlier and prevent more cases of cervical cancer than administering pap smears alone.

18 Dec 2011

Hologic receives FDA approval for Cervista HTA system to detect cervical cancer

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that the U.S. Food and Drug Administration (FDA) has approved its Cervista HTA (high throughput automation) system for use with the Company's previously approved Cervista human papillomavirus (HPV) HR test.

From Hologic, Inc. 16 Dec 2011

Gynaecological cancer survival rates have improved in Eastern England

Gynaecological cancer survival rates have improved in Eastern England following the reorganisation of services and multidisciplinary team working finds a new study published in the gynaecological oncology themed issue of BJOG: An International Journal of Obstetrics and Gynaecology.

15 Dec 2011

Cancer screening: Is it necessary in the elderly?

There is a long ongoing debate on whether the elderly need to be routinely screened for cancers. A new survey shows that the majority of nearly 19 million Americans over age 75 dutifully get screened for breast, prostate, and colon cancers each year.

14 Dec 2011

U.S. DoD awards $11M to study two different ways to treat PTSD in war veterans

A team of researchers who have pioneered novel treatments for post-traumatic stress disorder (PTSD) has been awarded an $11 million, four-year grant from the U.S. Department of Defense to investigate the differences between virtual reality and traditional prolonged exposure therapy.

14 Dec 2011

Smoking, excess weight, unhealthy diets and alcohol cause cancer

More than 100,000 cancers - equivalent to one third of all those diagnosed in the UK each year - are being caused by smoking, unhealthy diets, alcohol and excess weight, according to new research by Cancer Research UK.

7 Dec 2011

Bush launches Pink Ribbon Red Ribbon project in Zambia

"Zambian President Michael Sata on Friday told former U.S. president George W. Bush that the West should help fight the scourge of maternal deaths in sub-Saharan Africa," Agence France-Presse reports, adding, "Bush is in Zambia on the second stop of a three-nation trip aimed at promoting efforts to fight diseases like cancer, AIDS and malaria."

6 Dec 2011